Explore 3 Stock Ideas & Industry Insights Download Free Report

AI/ML Innovations Inc

Company price
0.04 CAD 0.00(0%)
Last update at 2026-11-09T15:18:00Z
VOLUME
223000
Market Cap
8.89M

Momentum Score

…

AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers MaxYield, a device-agnostic ECG signal processing; and AI PrecisionPulse Neural Network for the analysis of biometric signals to detect cardiovascular anomalies and personalized health recommendations, as well as Health Gauge's solutions that capture vital signs, such as blood pressure, heart rate, and pulse wave velocity. It also engages in the research and development of health and wearable technologies; and sale of licenses and consulting services related to the company's technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. is headquartered in Victoria, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.04
Low
0.04
High
52 Week Price Range
0.03
Low
0.12
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

AI/ML Innovations Inc is a Canada-listed company with limited public disclosures that operates in the artificial intelligence and machine-learning sector. Long-term growth drivers for the industry include broader enterprise AI adoption, more data and cheaper cloud compute, which may benefit companies that commercialize scalable models or services. Investors may find exposure to the AI sector attractive if the company can demonstrate revenue traction and differentiation.

Material risks include limited disclosure, execution risk in commercializing products, strong competition from larger players and the likely need for additional financing.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.04
Dividend Yield
-
Revenue TTM
0.13M
Revenue Per Share
0.00
Gross Profit TTM
0.12M
Debt / Equity
-
ROE
-503.41%
Net Debt
0.16M
ROCE
-186.30%
Diluted EPS TTM
-0.03

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Income before tax -4.59M -3.29M -1.49M -3.55M -2.83M
Minority interest -0.00M 0.01M 0.07M 0.38M -0.22M
Net income -4.59M -3.28M -1.42M -3.17M -2.73M
Selling general administrative 4.50M 1.71M 1.45M 2.99M 1.37M
Gross profit 0.16M 0.29M 0.47M 0.07M -
Reconciled depreciation 0.03M 0.04M 0.04M 0.04M 0.00M
Ebit - - -1.35M -3.35M -1.60M
Ebitda - - - -3.44M -2.79M
Operating income -4.84M -1.62M -1.35M -3.35M -1.43M
Other operating expenses - - - 0.00M 0.03M
Interest expense 0.02M 0.05M 0.06M 0.07M 0.04M
Interest income 0.00M 0.00M - - -
Net interest income -0.03M -0.05M -0.06M -0.07M -0.04M
Total revenue 0.17M 0.60M 0.49M 0.07M 0.00M
Total operating expenses 5.00M 2.22M 1.83M 3.42M 1.43M
Cost of revenue 0.00M 0.31M 0.02M 0.00M -
Total other income expense net 0.28M -1.62M -0.09M -0.13M -1.35M
Net income from continuing ops -4.59M -3.29M -1.49M -3.55M -2.83M
Net income applicable to common shares - - -1.42M -3.17M -2.73M
Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Total assets 3.41M 0.33M 1.51M 2.04M 3.59M
Intangible assets 0.90M - - - -
Total liab 0.86M 1.54M 1.79M 1.55M 1.51M
Total stockholder equity 2.60M -1.17M -0.25M 1.08M 2.31M
Other current liab - - 0.06M 0.05M 0.05M
Common stock - - 25.79M 25.28M 23.74M
Capital stock 32.04M 27.12M 25.79M 25.28M 23.74M
Retained earnings -39.73M -34.81M -31.74M -30.70M -27.53M
Cash 1.99M 0.20M 0.00M 0.48M 3.37M
Total current liabilities 0.82M 1.54M 1.79M 1.46M 1.47M
Net debt - - 0.16M - -
Short long term debt 0.13M 0.13M 0.17M 0.13M 0.28M
Other stockholder equity - - 5.70M 6.51M 6.09M
Property plant equipment - - 0.04M 0.08M -
Total current assets 2.45M 0.33M 0.23M 0.90M 3.59M
Long term investments - 0.00M 1.24M 1.06M 0.00M
Net tangible assets - - -0.25M 1.08M 2.31M
Short term investments 0.01M 0.02M 0.01M 0.05M 0.12M
Net receivables 0.01M 0.02M 0.12M 0.02M 0.03M
Long term debt - - - 0.04M 0.04M
Inventory 0.00M 0.00M 0.00M 0.00M 0.00M
Accounts payable 0.31M 0.37M 0.56M 0.35M 0.32M
Non current assets total 0.97M 0.00M 1.28M 1.14M 0.00M
Capital lease obligations 0.07M 0.00M 0.05M 0.09M 0.00M
Breakdown 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Type yearly yearly yearly yearly yearly
Date 2025-04-30 2024-04-30 2023-04-30 2022-04-30 2021-04-30
Investments -0.00M -0.33M -0.21M -1.09M -1.09M
Change to liabilities - - 0.36M 0.03M -0.00M
Total cashflows from investing activities - - -0.21M -1.09M -0.01M
Net borrowings -0.03M -0.09M -0.06M -0.21M 0.02M
Total cash from financing activities 5.78M 2.16M 0.37M 1.22M 4.17M
Change to operating activities - - 0.25M -0.26M -0.13M
Net income -4.59M -3.28M -1.42M -3.17M -2.73M
Change in cash 1.79M 0.20M -0.47M -2.89M 3.23M
Begin period cash flow 0.20M 0.00M 0.48M 3.37M 0.14M
End period cash flow 1.99M 0.20M 0.00M 0.48M 3.37M
Total cash from operating activities -3.99M -1.64M -0.63M -3.02M -0.93M
Issuance of capital stock 6.14M 2.21M 0.29M 0.76M 3.75M
Depreciation 0.03M 0.04M 0.04M 0.04M 0.17M
Other cashflows from investing activities - - - -0.06M -0.06M
Dividends paid 0.00M 0.00M - - -
Change to inventory 0.00M 0.00M 0.00M -0.00M -0.00M
Change to account receivables - - -0.09M 0.01M 0.02M
Other cashflows from financing activities - - -0.01M -0.04M -0.07M
Change to netincome - - 0.22M 0.34M 1.74M
Capital expenditures 0.00M 0.00M 0.00M 0.00M 0.03M
Change in working capital 0.40M -0.17M 0.51M -0.23M -0.11M
Stock based compensation 0.41M 0.03M 0.09M 0.34M 0.48M
Other non cash items 0.03M 0.13M -0.01M -3.31M 0.19M
Free cash flow -3.99M -1.64M -0.65M -3.02M -0.93M

Peer Comparison*

Sector: Healthcare Industry: Health Information Services

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
AIML
AI/ML Innovations Inc
-
-%
0.04 - - 70.85 35.17 68.77 -3.59
AIDR
Rocket Doctor AI Inc
-0.01
1.06%
0.47 - - 1671.77 6.46 59.80 -0.39
NARA
Pangenomic Health Inc.
-
-%
0.30 - - - 5.38 - -0.11
DMED
Diagnamed Holdings Corp.
-0.01
14.29%
0.03 - - - 10.74 - -1.43
UDOC
UniDoc Health Corp.
0.01
11.11%
0.05 - - 10.64 668.99 10.94 -9.56

Profile*

AI/ML Innovations Inc

AI/ML Innovations Inc. operates in the digital healthcare business using artificial intelligence (AI) and machine learning (ML) in Canada. The company offers MaxYield, a device-agnostic ECG signal processing; and AI PrecisionPulse Neural Network for the analysis of biometric signals to detect cardiovascular anomalies and personalized health recommendations, as well as Health Gauge's solutions that capture vital signs, such as blood pressure, heart rate, and pulse wave velocity. It also engages in the research and development of health and wearable technologies; and sale of licenses and consulting services related to the company's technologies. The company was formerly known as AIML Resources Inc. and changed its name to AI/ML Innovations Inc. in November 2020. AI/ML Innovations Inc. is headquartered in Victoria, Canada.

645 Fort Street, Victoria, BC, Canada, V8W 1G2

778 405 0882

Name Title Year Born
Mr. John Paul Duffy President, CEO & Executive Chairman 1966
Mr. Terence Lee Chief Financial Officer 1988
Mr. Esmat Naikyar Chief Product Officer NA
Mr. Erik Suokas Chief Operating Officer NA
Dr. Alan Rabinowitz FACC, FRCPC Chief Medical Officer, Member of Medical Advisory Board & Director of Medical Partnerships NA
Ms. Andrea L. Ruth M.S. Head of Quality, Clinical, & Regulatory NA
Ms. Kendra Low BHK, M.B.A. Company Secretary 1980
Mr. Terence Lee Chief Financial Officer 1989

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Support

Hi! How can we help you today?

Loading…